List of Validated Bioanalytical Methods
Clinfarm Ltd: List of Validated Bioanalytical Methods (Oct18)
No. |
Defined Analyte* |
Species |
Matrix |
Method |
LLOQ, ng/ml |
1. |
Ademol |
Human |
Plasma |
LC-MS/MS |
1 |
2. |
Allopurinol & Oxypurinol |
Human |
Plasma |
LC-MS/MS |
50 & 100 |
3. |
Amlodipine* |
Human |
Plasma |
LC-MS/MS |
0.125; 0.25 |
4. |
Amoxicillin & Clavulanic Acid |
Human |
Plasma |
LC-MS/MS |
100 & 50 |
5. |
Atorvastatin |
Human |
Plasma |
LC-MS/MS |
0.2 |
6. |
Azithromycin |
Human |
Plasma |
LC-MS/MS |
5 |
7. |
Betamethasone |
Human |
Plasma |
LC-MS/MS |
0.1 |
8. |
Betamethasone Dipropionate |
Human |
Plasma |
LC-MS/MS |
0,5 |
9. |
Bisoprolol fumarate |
Human |
Plasma |
LC-MS/MS |
1.0 |
10. |
Candesartan* |
Human |
Plasma |
LC-MS/MS |
2.0 |
11. |
Candesartan & Hydrochlorothiazide |
Human |
Plasma |
LC-MS/MS |
2.0 & 5.0 |
12. |
Clopidogrel |
Human |
Plasma |
LC-MS/MS |
0.025 |
13. |
Diclofenac* |
Human |
Plasma |
LC-MS/MS |
10 |
14. |
Escitalopram |
Human |
Plasma |
LC-MS/MS |
0.25 |
15. |
Fenspiride |
Human |
Plasma |
LC-MS/MS |
2.0 |
16. |
Fensuccinal |
Human & Rabbit |
Plasma |
LC-MS/MS |
3,0 |
17. |
Gabapentin |
Human |
Plasma |
LC-MS/MS |
30 |
18. |
Hopantenic acid |
Human |
Plasma |
LC-MS/MS |
50 |
19. |
Hydrochlorothiazide* |
Human |
Plasma |
LC-MS/MS |
1.0; 2.5; 5 |
20. |
Indapamide |
Human |
Plasma |
LC-MS/MS |
0.5 |
21. |
Ipidacrine |
Human |
Plasma |
LC-MS/MS |
0.25 |
22. |
Irbesartan* |
Human |
Plasma |
LC-MS/MS |
25 |
23. |
Letrozole |
Human |
Plasma |
LC-MS/MS |
0.075 |
24. |
Lisinopril* |
Human |
Plasma |
LC-MS/MS |
1.0 |
25. |
Meloxicam |
Human |
Plasma |
LC-MS/MS |
5 |
26. |
Molsidomine |
Human |
Plasma |
LC-MS/MS |
0.5 |
27. |
Nalbuphine |
Human |
Plasma |
LC-MS/MS |
0.2 |
28. |
Naproxen |
Human |
Plasma |
LC-MS/MS |
500 |
29. |
Nebivololum |
Human |
Plasma |
LC-MS/MS |
5 |
30. |
Nimesulide |
Human |
Plasma |
LC-MS/MS |
20 |
31. |
Ondansetron |
Human |
Plasma |
LC-MS/MS |
0.25 |
32. |
Pregabalin |
Human |
Plasma |
LC-MS/MS |
20 |
33. |
Quercetin & Isoramnetin |
Human |
Plasma |
LC-MS/MS |
5&2.5 |
34. |
Quercetin & Its Metabolites |
Human & Rabbit |
Plasma |
LC-MS/MS |
25 |
35. |
Quercetin & Its Metabolites |
Human |
Urea |
LC-MS/MS |
25 |
36. |
Ramipril & Ramiprilat |
Human |
Plasma |
LC-MS/MS |
0.5 & 0.5 |
37. |
Rebamipide |
Human |
Plasma |
LC-MS/MS |
2 |
38. |
Riluzole |
Human |
Plasma |
LC-MS/MS |
2.0 |
39. |
Rizatriptan |
Human |
Plasma |
LC-MS/MS |
0.25 |
40. |
Rosuvastatin Calcium |
Human |
Plasma |
LC-MS/MS |
0.5 |
41. |
Tadalafil |
Human |
Plasma |
LC-MS/MS |
2 |
42. |
Thioctic acid (Lipoic acid) |
Human |
Plasma |
LC-MS/MS |
25 |
43. |
Thiotriazoline// Thiazotic acid |
Human |
Plasma |
LC-MS/MS |
10 |
44. |
Tolperisone |
Human |
Plasma |
LC-MS/MS |
0,5 |
45. |
Trihexyphenidyl |
Human |
Plasma |
LC-MS/MS |
0.2 |
46. |
Trimetazidine |
Human |
Plasma |
LC-MS/MS |
1.0 |
47. |
Trimethylhydrazinium propionate(Meldonium) |
Human |
Plasma |
LC-MS/MS |
10 |
48. |
Uridine (metabolite of CDP-choline) |
Human |
Plasma |
LC-MS/MS |
50 |
49. |
Valproic acid |
Human |
Plasma |
LC-MS |
500 |
50. |
Valsartan* |
Human |
Plasma |
LC-MS/MS |
40 |
51. |
Valsartan & Amlodipine |
Human |
Plasma |
LC-MS/MS |
40 & 0.25 |
* Примечание: Указанные БАМ применимы для комбинаций исследуемых аналитов.
* Note: the BAM applicable to combinations of analytes studied.
Поделиться в социальных сетях: